89 related articles for article (PubMed ID: 7745821)
21. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
22. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
Lygidakis NJ; Papadopoulou P
Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of pancreatic adenocarcinoma: Taiwan experience.
Jan YY; Chen MF; Wang CS; Jeng LB; Hwang TL; Chen SC
Int Surg; 1996; 81(1):52-6. PubMed ID: 8803707
[TBL] [Abstract][Full Text] [Related]
25. Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head.
Gazzaniga GM; Papadia FS; Dezzana M; Cappato S; Filauro M; Bandelloni R
Hepatogastroenterology; 2001; 48(42):1743-5. PubMed ID: 11813614
[TBL] [Abstract][Full Text] [Related]
26. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.
Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S
Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic carcinoma incidence and survival in Sweden in 1980-2000: a population-based study of 16,758 hospitalized patients with special reference to different therapies.
Linder S; Boström L; Nilsson B
Eur J Surg Oncol; 2007 Jun; 33(5):616-22. PubMed ID: 17317081
[TBL] [Abstract][Full Text] [Related]
29. Total pancreatectomy. An objective analysis of its use in pancreatic cancer.
Sarr MG; Behrns KE; van Heerden JA
Hepatogastroenterology; 1993 Oct; 40(5):418-21. PubMed ID: 7903658
[TBL] [Abstract][Full Text] [Related]
30. [Palliative procedures in the treatment of non-resectable pancreatic tumors. Retrospective study of 294 cases and review of the literature].
Proposito D; Santoro R; Mancini B; Gallina S; Carboni M
Ann Ital Chir; 1998; 69(2):185-93. PubMed ID: 9718787
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
32. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
33. Does the surgical stress associated with palliative resection for patients with incurable gastric cancer with distant metastasis shorten their survival?
Moriwaki Y; Kunisaki C; Kobayashi S; Harada H; Imai S; Kasaoka C
Hepatogastroenterology; 2004; 51(57):872-5. PubMed ID: 15143937
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
35. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
[TBL] [Abstract][Full Text] [Related]
36. [Resectability of primary carcinoma of the liver and pancreas, with special reference to radicality and functional reserve].
Noguchi T; Kita T; Mizumoto R
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1137-43. PubMed ID: 3382189
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic intraglandular metastasis predicts poorer outcome in postoperative patients with pancreatic ductal carcinoma.
Oguro S; Shimada K; Ino Y; Esaki M; Nara S; Kishi Y; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2013 Jul; 37(7):1030-8. PubMed ID: 23648465
[TBL] [Abstract][Full Text] [Related]
38. [Pancreatic ductal carcinoma. Intra- and postoperative complications in palliative and curative interventions].
Volk H
Zentralbl Chir; 1991; 116(7):447-52. PubMed ID: 1711747
[TBL] [Abstract][Full Text] [Related]
39. [An appraisal of the surgical management of stage I and II cancers of the pancreas].
Manabe T; Naitoh A; Suzuki T; Tobe T
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1089-92. PubMed ID: 4088216
[TBL] [Abstract][Full Text] [Related]
40. Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma.
Nordby T; Ikdahl T; Bowitz Lothe IM; Fagerland MW; Heiberg T; Hauge T; Labori KJ; Buanes T
Pancreatology; 2013; 13(2):180-5. PubMed ID: 23561977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
